Asia-Pacific Pneumatic Tourniquet Market Size, Share & Trends Analysis Report by Type (Single Bladder Tourniquet, and Double Bladder Tourniquet), Application (Intravenous Regional Anesthesia, Orthopedic, and Others), Country and Growth Forecast, 2024-2031

The Asia Pacific Pneumatic Tourniquet Market is projected to witness market growth of 7.5% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Pneumatic Tourniquet Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $49.56 millions by 2031. The Japan market is registering a CAGR of 7% during 2024-2031. Additionally, the India market would showcase a CAGR of 8.2% during 2024-2031.



Various factors, including technological advancements, healthcare needs, and regulatory standards, have influenced the adoption of these tourniquets. Their integration into medical practice has seen significant growth, driven by their benefits in surgical precision, trauma management, and overall patient care. Modern tourniquets have advanced features such as digital pressure monitoring, automatic inflation and deflation, and real-time feedback systems. These technological innovations enhance precision and ease of use, making them more appealing to healthcare providers.

Moreover, due to factors like an aging population and an increase in chronic conditions, the growing number of elective and emergency surgeries has intensified the demand for these tourniquets. Their ability to provide a clear surgical field is essential for many surgeries. Expanding specialized surgical fields, such as orthopedics, plastic surgery, and trauma surgery, further drives the need for these tourniquets, as these procedures often require precise blood flow control.

The increase in China’s medical device industry facilitates the local production of these tourniquets, reducing import dependency and allowing for more cost-effective and customized solutions tailored to local market needs. According to the International Trade Administration (ITA), the medical device industry in China is expected to expand at a rate of 8.3% from 2021 to 2026, reaching $48.8 billion by 2026. Furthermore, the higher volume of elective surgeries in Australia drives a greater demand for these tourniquets. The variety of elective surgeries, including orthopedic, plastic, and vascular surgeries, increases the need for these tourniquets tailored to different surgical specialties, fostering market growth and diversity. The Australian Government of Health and Welfare reports that public hospital elective surgery waiting lists admitted 7,35,500 patients for surgery in 2022-23, representing an 18% increase from 2021-22. Hence, the expansion of the medical device industry and the high number of admissions for elective surgeries in the region are driving the market's growth.

Based on Type, the market is segmented into Single Bladder Tourniquet, and Double Bladder Tourniquet. Based on Application, the market is segmented into Intravenous Regional Anesthesia, Orthopedic, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Ane-c Aid Ltd.
• Stryker Corporation
• VBM Medizintechnik GmbH
• Zimmer Biomet Holdings, Inc.
• SPENGLER HOLTEX Group
• Shanghai Huifeng Medical Instrument Co., Ltd.
• Jiangsu Qianjing Medical Equipment Co.,Ltd (Jiangsu Qianjing Technology Development Group)
• The Seaberg Company Inc. (SAM Medical)
• Hammarplast Medical AB
• OHK Medical Devices, Inc.

Market Report Segmentation

By Type

• Single Bladder Tourniquet
• Double Bladder Tourniquet

By Application

• Intravenous Regional Anesthesia
• Orthopedic
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific